✦ LIBER ✦

Optimal dose de-escalation trial designs for novel contraceptives in women

✍ Scribed by Christoph Gerlinger; Harald Siedentop; Oke Gerke; Ilka Schellschmidt; Jan Endrikat

Book ID: 113557692
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 220 KB
Volume: 56
Category: Article
ISSN: 0167-9473
DOI: 10.1016/j.csda.2011.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal multi-stage designs for a phase

Optimal multi-stage designs for a phase II trial that permits one dose escalation

✍ John J. Hanfelt 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Simon's optimal two-stage design is widely used to conduct single-dose phase II clinical trials. We extend this basic methodology to the situation where the researcher desires to test an experimental drug for activity at a low dose level, but is willing to increase the dose part-way through the tria

Safety and dose-escalation study design

Safety and dose-escalation study design of Transcranial Ultrasound in Clinical SONolysis for acute ischemic stroke: the TUCSON Trial

✍ Andrew D. Barreto; Vijay K. Sharma; Annabelle Y. Lao; Peter D. Schellinger; Pier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

The Neuroprotection with Statin Therapy

The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke

✍ Mitchell S. V. Elkind; Ralph L. Sacco; Robert B. MacArthur; Daniel J. Fink; Elli 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Dose escalation trial of the efficacy, s

Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial

✍ C. Michael Gibson; Cafer Zorkun; Peter Molhoek; Krzysztof Żmudka; Mark Greenberg 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 295 KB

A randomized hypofractionation dose esca

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients

✍ Norkus, Darius; Karklelyte, Agata; Engels, Benedikt; Versmessen, Harijati; Grisk 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 280 KB

Immunogenicity and safety of a novel the

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects

✍ Christa Firbas; Bernd Jilma; Erich Tauber; Vera Buerger; Sandra Jelovcan; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 207 KB